Tag

Ftc Lawsuit

All articles tagged with #ftc lawsuit

business2 months ago

Ticketmaster to Ban Multiple Accounts and Shut Down TradeDesk Amid FTC Lawsuit

Ticketmaster announced it will ban users from having multiple accounts and will shut down its TradeDesk platform following a lawsuit by the FTC accusing the company of colluding with scalpers and violating the BOTS Act. The company claims these practices are standard industry behavior and denies the allegations, but acknowledges that the use of multiple accounts has been abused. The policy change aims to address concerns about scalping and protect the integrity of ticket sales.

business2 months ago

Ticketmaster to Ban Multiple Accounts and Shut Down TradeDesk Amid FTC Lawsuit

Ticketmaster announced policy changes including banning multiple accounts, shutting down TradeDesk, and requiring Social Security numbers from brokers following an FTC lawsuit accusing it of anti-competitive practices and bot violations. The company defends its actions, disputes the FTC's claims, and emphasizes efforts to combat scalping and fraud, while also shifting the narrative to focus on technological and legislative issues related to ticketing and bots.

business3 months ago

FTC Sues Live Nation and Ticketmaster Over Illegal Ticket Resale Practices

The FTC and seven states have sued Live Nation and Ticketmaster, accusing them of allowing ticket brokers to resell tickets at high markups, violating consumer protection laws and contributing to unfair ticket pricing, especially highlighted during the Taylor Swift Eras tour ticket sales. The lawsuit alleges that Ticketmaster ignored violations by resellers and failed to disclose full ticket prices, with the companies facing ongoing legal challenges over market monopolization.

world4 months ago

FTC sues ticket resellers over Taylor Swift and major concert ticket scandals

The FTC has sued Maryland-based Key Investment Group for illegally purchasing and reselling hundreds of thousands of tickets, including thousands for Taylor Swift's Eras Tour, at inflated prices by bypassing Ticketmaster's security measures. The company allegedly used thousands of accounts and virtual credit cards to circumvent purchase limits, making over $64 million from resales, violating federal laws. The case highlights ongoing issues with ticket scalping and online security measures.

business2 years ago

Amazon Sellers' Livelihoods Thrived Until Amazon's Revelation

Amazon is facing a federal lawsuit filed by the Federal Trade Commission (FTC) and 17 state attorneys general, accusing the company of using its monopoly power to harm independent sellers. The lawsuit alleges that Amazon punishes third-party sellers offering lower prices on other platforms, forces them to use its shipping service, and increases fees indiscriminately. Many third-party sellers have experienced success on Amazon only to later lose everything, as the company competes with and replicates their products. The lawsuit highlights the precarious position of third-party sellers on Amazon, where sudden changes can have devastating consequences. Critics argue that Amazon's dominance necessitates more competition and potential breakup to protect consumers and promote a better online experience.

business2 years ago

South Africa Joins in Approving Microsoft's Activision Blizzard Acquisition

Microsoft's acquisition of Activision Blizzard has received unconditional approval from South Africa's Competition Commission, making it the latest global regulatory body to approve the deal. The commission stated that it has no significant concerns about Microsoft making Call of Duty exclusive to Xbox, as Microsoft does not have the ability or incentive to do so. The approval comes amidst an ongoing lawsuit in the US between Microsoft, Activision Blizzard, and the Federal Trade Commission. The UK's ruling is expected by April 26, while the US approval is still pending.

business2 years ago

FTC Lawsuit Doesn't Deter Amgen's $28B Deal with Horizon, Analysts Remain Optimistic.

Amgen CEO, Robert Bradway, remains confident that the $28 billion deal with Horizon Therapeutics will close despite the FTC lawsuit filed to block the merger. The FTC argues that the merger would allow Amgen to use rebates on its existing drugs to pressure insurance companies and pharmacy benefit managers into favoring Horizon’s thyroid eye disease and chronic refractory gout products. The lawsuit is expected to have a significant impact on M&A enthusiasm across the biopharma sector.